Literature DB >> 4907150

Evidence for an inhibitor of insulin release in the pancreatic islets.

B Hellman, A Lernmark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4907150     DOI： 10.1007/bf01212214

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  A METHOD FOR THE MICRODISSECTION OF INTACT PANCREATIC ISLETS OF MAMMALS.

Authors:  C HELLERSTROEM
Journal:  Acta Endocrinol (Copenh)       Date:  1964-01

2.  [INSULIN SECRETION IN VITRO. I. INHIBITION OF GLUCOSE-INDUCED INSULIN RELEASE BY INSULIN].

Authors:  H FRERICHS; U REICH; W CREUTZFELDT
Journal:  Klin Wochenschr       Date:  1965-02-01

3.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

4.  Quantitative histochemistry of the islets of Langerhans. II. Insulin content of dissected beta cells.

Authors:  P E LACY; J R WILLIAMSON
Journal:  Diabetes       Date:  1962 Mar-Apr       Impact factor: 9.461

5.  Quantitative and qualitative aspects of islet function in the rat.

Authors:  W J Malaisse; F Malaisse-Lagae; S King
Journal:  J Lab Clin Med       Date:  1968-01

6.  Quantitative studies on isolated pancreatic islets of mammals. Activity and heterogeneity of lactate dehydrogenase in obese-hyporglycemic mice.

Authors:  B Hellman; I B Täljedal
Journal:  Endocrinology       Date:  1967-07       Impact factor: 4.736

7.  Studies in obese-hyperglycemic mice.

Authors:  B Hellman
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

8.  Development of the obese-hyperglycaemic syndrome in mice.

Authors:  S Westman
Journal:  Diabetologia       Date:  1968-06       Impact factor: 10.122

9.  Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon.

Authors:  E Samols; G Marri; V Marks
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

10.  Insulin secretion by isolated islets in presence of glucose, insulin and anti-insulin serum.

Authors:  W J Malaisse; F Malaisse-Lagae; P E Lacy; P H Wright
Journal:  Proc Soc Exp Biol Med       Date:  1967-02
View more
  8 in total

1.  The autoregulation of insulin secretion in the isolated pancreatic islets of lean (obOb) and obese-hyperglycemic (obob) mice.

Authors:  L Loreti; J C Dunbar; S Chen; P P Foà
Journal:  Diabetologia       Date:  1974-08       Impact factor: 10.122

2.  Ultrastructural and biometric action of insulin on foetal rat pancreas.

Authors:  H Perrier; R Jacquot
Journal:  Diabetologia       Date:  1972-11       Impact factor: 10.122

3.  Plasminogen activator of islets of Langerhans: modulation by glucose and correlation with insulin production.

Authors:  M A Virji; J D Vassalli; R D Estensen; E Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

4.  [Isolated mouse islets as a model for studying insulin release].

Authors:  A Lernmark
Journal:  Acta Diabetol Lat       Date:  1971 Jul-Aug

5.  Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic β-cells.

Authors:  Jie Wang; Ying Chen; Qingxin Yuan; Wei Tang; Xiaoping Zhang; Kwame Osei
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Proinsulin atypical maturation and disposal induces extensive defects in mouse Ins2+/Akita β-cells.

Authors:  Qingxin Yuan; Wei Tang; Xiaoping Zhang; Jack A Hinson; Chao Liu; Kwame Osei; Jie Wang
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

7.  Somatostatin in renal physiology and autosomal dominant polycystic kidney disease.

Authors:  A Lianne Messchendorp; Niek F Casteleijn; Esther Meijer; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

Review 8.  The somatostatin-secreting pancreatic δ-cell in health and disease.

Authors:  Patrik Rorsman; Mark O Huising
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.